Table 2.
n | ICS 0 | ICS 1 | ICS 2 | p-value | |
Metastases | 67 | 10.0% | 25.5% | 47.0% | 0.046 * |
Primary tumours | 62 | 11.1% | 41.9% | 0.0% | 0.152 |
n | PD-1 (TC) low | PD-1 (TC), high | p | ||
Metastases | 67 | 23.5% | 33.6% | 0.114 | |
Primary tumours | 61 | 29.3% | 27.2% | 0.726 | |
n | PD-1 (IM) low | PD-1 (IM), high | p | ||
Metastases | 63 | 23.8% | 39.7% | 0.066 | |
Primary tumours | 60 | 20.7% | 42.5% | 0.328 | |
n | PD-L1 (TCe) low | PD-L1 (TCe), high | p | ||
Metastases | 67 | 23.3% | 100.0% | 0.024 | |
Primary tumours | 60 | 28.2% | 0.0% | 0.328 | |
n | PD-L1 (IC) low | PD-L1 (IC), high | p | ||
Metastases | 66 | 27.3% | 27.7% | 0.943 | |
Primary tumours | 60 | 32.4% | 13.9% | 0.086 |
* Statistically significant at the 0.05 level.